Loading clinical trials...
Loading clinical trials...
Impedance Spectroscopy Using the ONIRY Device in the Diagnosis of Sphincter Injuries in Women After Vaginal Deliveries
The main purpose of the study is to evaluate the effectiveness and safety of the impedance spectroscopy device prototype in the detection of anal sphincter injuries in women in the early postpartum period. The study is prospective. The study group comprises up to 56 patients; up to 16 weeks from a natural delivery. The planned participation of each patient in the study is up to 4 weeks and two visits will take place at that time. After obtaining written consent, at the first visit (V1) each patient will undergo a physical examination (both proctological and gynecological examination), blood samples for laboratory tests and stool samples for calprotectin concentration assessment will be collected. The presence of clinical symptoms of both gas and stool incontinence will be assessed during the visit with the use of Wexner's scale. Then, the dates of two reference tests will be planned: Trans-rectal USG and Recto-anal manometry which will be performed as part of the V1 visit within a period not exceeding 27 days. The V2 visit, which will also be the final visit, will include a reassessment of the patient's general condition, recording the values of basic vital parameters, subjective and physical examination, and then the doctor conducting the examination will finally determine the extent of sphincter damage, present the patient with therapeutic options and decide on the treatment or rehabilitation of sphincter. During the visits, all adverse events will also be monitored, both those reported by patients and those related to the examined diagnostic device.
Age
18 - 49 years
Sex
FEMALE
Healthy Volunteers
No
Praktyka Lekarska Małgorzata Uchman-Musielak
Warsaw, Masovian Voivodeship, Poland
Start Date
October 15, 2019
Primary Completion Date
June 26, 2020
Completion Date
July 20, 2020
Last Updated
September 16, 2020
49
ACTUAL participants
Blood and faeces tests
DIAGNOSTIC_TEST
Impedance spectroscopy test
DEVICE
Full gynecological and proctological examination
DIAGNOSTIC_TEST
Transanal ultrasonography
DIAGNOSTIC_TEST
Anorectal manometry
DIAGNOSTIC_TEST
Determining the degree of sphincter injury
OTHER
Lead Sponsor
OASIS Diagnostics S.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05832268